91 results
8-K
EX-10.1
RGBP
Regen BioPharma Inc
25 Mar 21
Departure of Directors or Certain Officers
12:00am
and development information; matters of a technical nature, including technology; notes, products, know-how, engineering or other data (including test data … therewith. Consultant shall advise its Representatives who have access to the Company’s Proprietary Information of the confidential and proprietary nature
8-K
EX-10.1
RGBP
Regen BioPharma Inc
25 Jan 19
Departure of Directors or Certain Officers
4:00pm
, confidential information, ideas, inventions or research and development information; matters of a technical nature, including technology; notes, products, know … Proprietary Information of the confidential and proprietary nature thereof, and agrees that such Representatives shall be bound by terms
8-K
EX-99.1
n8lg5uwr9e xuuw
12 Nov 21
Other Events
10:00am
8-K
EX-10.1
saesxq
22 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
80xwb
22 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
edgvkio9h7lrqn96u
8 Apr 21
Entry into a Material Definitive Agreement
10:08am
8-K
EX-10.2
u6gs7 5zzlr0zz
8 Apr 21
Entry into a Material Definitive Agreement
10:08am
8-K
EX-10.1
789axwqe4lt pyfvlfi4
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
mq4hdap eobxbb
16 Sep 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
xy9 v2hmw3t
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.2
kvha8 w2gjjny5yvqc
24 Sep 21
Entry into a Material Definitive Agreement
12:00pm